Breast cancer drug may throw patients off balance, study finds
NCT ID NCT06184074
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at 76 postmenopausal women with breast cancer to see if aromatase inhibitors affect balance and fall risk. Half the women had been taking the drug for at least a year, the other half never took it. Researchers measured balance using special tests and questionnaires. The goal is to understand if these common drugs increase the chance of falling.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aromatase inhibitors
- What this could lead to
- If this study finds clear links, it could help doctors monitor balance issues in breast cancer patients on aromatase inhibitors and possibly reduce fall risk.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AROMATASE INHIBITORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ece Küçük
Istanbul, 34457, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?